Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun 20:10:663.
doi: 10.3389/fneur.2019.00663. eCollection 2019.

Potential of Prebiotic Butyrogenic Fibers in Parkinson's Disease

Affiliations
Review

Potential of Prebiotic Butyrogenic Fibers in Parkinson's Disease

Thaisa M Cantu-Jungles et al. Front Neurol. .

Abstract

Parkinson's Disease (PD) is a neurodegenerative disorder characterized by loss of dopaminergic neurons in the substantia nigra. Recent evidence supports the involvement of the gastrointestinal tract in PD pathogenesis, including alterations in microbiota and intestinal permeability. Apart from being the preferred energy source for colonic epithelial cells, butyrate is involved in anti-inflammatory, enteroendocrine and epigenetic mechanisms that influence colonic and systemic health, including brain function. A few studies using oral administration of sodium butyrate indicate beneficial effects in PD animal models; however, prebiotic fibers that generate butyrate locally in the gut may be more effective. The design and selection of butyrogenic prebiotic fibers would allow preclinical studies to evaluate how gut-derived butyrate could affect PD pathophysiology. This review describes potential benefits of increasing gut butyrate production in PD through a prebiotic approach. Moreover, physico-chemical features of prebiotic fibers that target butyrogenic colonic bacteria are discussed.

Keywords: Parkinson's disease; butyrate; dietary fiber; gut microbiota; prebiotics.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Dietary fiber approach to increase gut-produced butyrate and pathways that have potential benefits to Parkinson's Disease. Insoluble dietary fibers with specific chemical structures are fermented by butyrate producers in the gut (e.g., Clostridium Cluster XIVa and IV species). The butyrate produced during fermentation supports gut barrier function through the stimulation of mucus production and tight junction assemblies, and minimizing antigen translocation and inflammation. Butyrate also regulates inflammatory pathways through G protein-coupled receptors (GPCR) in enterocytes and through inhibition of histone deacetylase (HDAC) in macrophages. GPCR signaling in enteroendocrine cells (EEC) induce secretion of hormones (e.g., glucagon-like peptide-1 [GLP-1] and peptide YY[PYY]) that act in many organs, including the brain.

References

    1. Thomas B, Beal M. Parkinson's disease. Hum Mol Genet. (2007) 16:R138–94. 10.1093/hmg/ddm159 - DOI - PubMed
    1. Braak H, Del Tredici K. Nervous system pathology in sporadic Parkinson disease. Neurology. (2008) 70:1916–25. 10.1212/01.wnl.0000312279.49272.9f - DOI - PubMed
    1. Hawkes CH, Del Tredici K, Braak H. Parkinson's disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol. (2007) 33:599–614. 10.1111/j.1365-2990.2007.00874.x - DOI - PMC - PubMed
    1. Lebouvier T, Chaumette T, Paillusson S, Duyckaerts C, Bruley des Varannes S, Neunlist M, et al. The second brain and Parkinson's disease. Eur J Neurosci. (2009) 30:735–41. 10.1111/j.1460-9568.2009.06873.x - DOI - PubMed
    1. Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS ONE. (2011) 6:e28032. 10.1371/journal.pone.0028032 - DOI - PMC - PubMed

LinkOut - more resources